- Clinical Interests
- Brain and spinal cord tumors
- Primary brain tumors
- Neurocutaneous syndrome
- Clinical research
- Lymphomas of the nervous system
- Medical Education
- MD, University of Texas Medical School
- Residency, UT Southwestern Medical/Parkland
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Foreign Languages
- Boston: Massachusetts General Hospital
- Danvers: The Mass General/North Shore Center for Outpatient Care
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Dr. Jordan earned his bachelor's degree in biology in 2004 from Texas Christian University, then his MD from the University of Texas Medical School in Houston. During that time he performed basic science and translational research on brain tumor immunology at the University of Texas M.D. Anderson Cancer Center in Houston. He then completed his neurology residency at the University of Texas Southwestern Medical Center in Dallas, where he served as chief resident. He trained in the neuro-oncology fellowship at the joint program of Massachusetts General Hospital, Dana Farber Cancer Institute, and Brigham and Women's Hospital. In his second year of fellowship, he concentrated on the neurofibromatoses and allied disorders and enrolled in a Masters of Public Health degree program at the Harvard T.H. Chan School of Public Health, which he completed in November 2016. He joined the clinical faculty of the Pappas Center for Neuro-Oncology and the Family Center for Neurofibromatosis in February 2015, and became Clinical Director of the MGH Brain Tumor Center in July 2017.
Dr. Jordan's clinical interests are in primary nervous system tumors and in neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis. His research interests are in the genetics of tumor development within these tumor predisposition syndromes, as well as therapeutic clinical trials for malignant brain tumors. He is also involved in clinical process improvement for brain tumor care at MGH, and contributes to patient care quality measurement development within the American Academy of Neurology and the Society for Neuro-Oncology.
- Jordan JT*, Sun W*, Hussain SF, Deangulo G, Prabhu SS, Heimberger AB. Preferential Migration of Regulatory T Cells Mediated by Glioma-Secreted Chemokines can be Blocked with Chemotherapy. Cancer Immunol Immunother. 2008 Jan; 57(1):123-31. * Denotes co-first authors
- Beauchamp RL, James MF, DeSouza PA, Wagh V, Zhao W, Jordan JT, Stemmer-Rachamimov A, Plotkin SR, Gusella JF, Haggarty SJ, Ramesh V. “A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas” OncoTarget. 2015 July 15; 6(19):16981-16997.
- Terry AR, Jordan JT, Schwamm L, Plotkin SR. “Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: A population-based approach” Stroke. 2016 Jan; 47(1):60-5.
- Field KM*, Jordan JT*, Wen PY, Rosenthal MA, Reardon DA. Bevacizumab and Glioblastoma: Scientific Review, Newly Reported Updates, and Ongoing Controversies. April 1, 2015. * Denotes co-first authors
- Jordan JT, Gerstner ER, Batchelor TT, Cahill DP, Plotkin, SR. Glioblastoma Care in the Elderly. Cancer. 2016 Jan 15;122(2):189-97.
- Justin T. Jordan and Patrick Y. Wen. “Novel Chemotherapeutic Approaches in High-Grade Gliomas”, in Current Understanding and Treatment of Gliomas. Cancer Treatment and Research. Volume 163, 2015, pp117-142
Research at the MGH is interwoven throughout more than 30 departments, centers and units and is conducted with the support and guidance of the MGH Research Institute. The Research Roundup is a monthly series highlighting studies, news and events.
55 Fruit Street
Boston, MA 02114
102 Endicott Street
Danvers, MA 01923-3623